DprE1 – from the Discovery to the Promising Tuberculosis Drug Target

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|27|4379-4403

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.27, 2014-08, pp. : 4379-4403

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peptide deformylase – a promising therapeutic target for tuberculosis and antibacterial drug discovery

By Sharma Anshika   Khuller Gopal K   Sharma Sadhna  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 753-765

Informa Healthcare

Access to resources Recommend Favorite

Adrenomedullin: a new and promising target for drug discovery

By García Mario A   Martín-Santamaría Sonsoles   de Pascual-Teresa Beatriz   Ramos Ana   Julián Miguel   Martínez Alfredo  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 303-317

Informa Healthcare

Access to resources Recommend Favorite

Navigating tuberculosis drug discovery with target-based screening

By Miller Christopher H   O'Toole Ronan F  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 8, 2011-08 ,pp. : 839-854

Informa Healthcare

Access to resources Recommend Favorite

Mycobacterium tuberculosis DNA Gyrase as a Target for Drug Discovery

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 2, 2007-01 ,pp. : 159-168

Bentham Science Publishers

Access to resources Recommend Favorite

FtsZ: A Novel Target for Tuberculosis Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-03 ,pp. : 527-543

Bentham Science Publishers

Access to resources Recommend Favorite